Literature DB >> 17668386

Permanent neonatal diabetes caused by dominant, recessive, or compound heterozygous SUR1 mutations with opposite functional effects.

Sian Ellard1, Sarah E Flanagan, Christophe A Girard, Ann-Marie Patch, Lorna W Harries, Andrew Parrish, Emma L Edghill, Deborah J G Mackay, Peter Proks, Kenju Shimomura, Holger Haberland, Dennis J Carson, Julian P H Shield, Andrew T Hattersley, Frances M Ashcroft.   

Abstract

Heterozygous activating mutations in the KCNJ11 gene encoding the pore-forming Kir6.2 subunit of the pancreatic beta cell K(ATP) channel are the most common cause of permanent neonatal diabetes (PNDM). Patients with PNDM due to a heterozygous activating mutation in the ABCC8 gene encoding the SUR1 regulatory subunit of the K(ATP) channel have recently been reported. We studied a cohort of 59 patients with permanent diabetes who received a diagnosis before 6 mo of age and who did not have a KCNJ11 mutation. ABCC8 gene mutations were identified in 16 of 59 patients and included 8 patients with heterozygous de novo mutations. A recessive mode of inheritance was observed in eight patients with homozygous, mosaic, or compound heterozygous mutations. Functional studies of selected mutations showed a reduced response to ATP consistent with an activating mutation that results in reduced insulin secretion. A novel mutational mechanism was observed in which a heterozygous activating mutation resulted in PNDM only when a second, loss-of-function mutation was also present.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17668386      PMCID: PMC1950816          DOI: 10.1086/519174

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  20 in total

1.  The essential role of the Walker A motifs of SUR1 in K-ATP channel activation by Mg-ADP and diazoxide.

Authors:  F M Gribble; S J Tucker; F M Ashcroft
Journal:  EMBO J       Date:  1997-03-17       Impact factor: 11.598

Review 2.  From molecule to malady.

Authors:  Frances M Ashcroft
Journal:  Nature       Date:  2006-03-23       Impact factor: 49.962

Review 3.  RET mutations in human disease.

Authors:  B Pasini; I Ceccherini; G Romeo
Journal:  Trends Genet       Date:  1996-04       Impact factor: 11.639

4.  Functional effects of mutations at F35 in the NH2-terminus of Kir6.2 (KCNJ11), causing neonatal diabetes, and response to sulfonylurea therapy.

Authors:  Peter Proks; Christophe Girard; Halvor Baevre; Pål R Njølstad; Frances M Ashcroft
Journal:  Diabetes       Date:  2006-06       Impact factor: 9.461

5.  Decreased tolbutamide-stimulated insulin secretion in healthy subjects with sequence variants in the high-affinity sulfonylurea receptor gene.

Authors:  T Hansen; S M Echwald; L Hansen; A M Møller; K Almind; J O Clausen; S A Urhammer; H Inoue; J Ferrer; J Bryan; L Aguilar-Bryan; M A Permutt; O Pedersen
Journal:  Diabetes       Date:  1998-04       Impact factor: 9.461

6.  Cross sectional stature and weight reference curves for the UK, 1990.

Authors:  J V Freeman; T J Cole; S Chinn; P R Jones; E M White; M A Preece
Journal:  Arch Dis Child       Date:  1995-07       Impact factor: 3.791

7.  Mutations in KCNJ11, which encodes Kir6.2, are a common cause of diabetes diagnosed in the first 6 months of life, with the phenotype determined by genotype.

Authors:  S E Flanagan; E L Edghill; A L Gloyn; S Ellard; A T Hattersley
Journal:  Diabetologia       Date:  2006-04-12       Impact factor: 10.122

Review 8.  Activating mutations in Kir6.2 and neonatal diabetes: new clinical syndromes, new scientific insights, and new therapy.

Authors:  Andrew T Hattersley; Frances M Ashcroft
Journal:  Diabetes       Date:  2005-09       Impact factor: 9.461

9.  A heterozygous activating mutation in the sulphonylurea receptor SUR1 (ABCC8) causes neonatal diabetes.

Authors:  Peter Proks; Amanda L Arnold; Jan Bruining; Christophe Girard; Sarah E Flanagan; Brian Larkin; Kevin Colclough; Andrew T Hattersley; Frances M Ashcroft; Sian Ellard
Journal:  Hum Mol Genet       Date:  2006-04-13       Impact factor: 6.150

10.  Activating mutations in the ABCC8 gene in neonatal diabetes mellitus.

Authors:  Andrey P Babenko; Michel Polak; Hélène Cavé; Kanetee Busiah; Paul Czernichow; Raphael Scharfmann; Joseph Bryan; Lydia Aguilar-Bryan; Martine Vaxillaire; Philippe Froguel
Journal:  N Engl J Med       Date:  2006-08-03       Impact factor: 91.245

View more
  63 in total

Review 1.  Permanent neonatal diabetes due to activating mutations in ABCC8 and KCNJ11.

Authors:  Emma L Edghill; Sarah E Flanagan; Sian Ellard
Journal:  Rev Endocr Metab Disord       Date:  2010-09       Impact factor: 6.514

Review 2.  Pancreatic β-cell KATP channels: Hypoglycaemia and hyperglycaemia.

Authors:  Kate Bennett; Chela James; Khalid Hussain
Journal:  Rev Endocr Metab Disord       Date:  2010-09       Impact factor: 6.514

3.  Detection of KCNJ11 gene mutations in a family with neonatal diabetes mellitus: implications for therapeutic management of family members with long-standing disease.

Authors:  Farzaneh Abbasi; Sadaf Saba; Azadeh Ebrahim-Habibi; Forough A Sayahpour; Parvin Amiri; Bagher Larijani; Mahsa M Amoli
Journal:  Mol Diagn Ther       Date:  2012-04-01       Impact factor: 4.074

Review 4.  Neonatal diabetes mellitus: a model for personalized medicine.

Authors:  Siri Atma W Greeley; Susan E Tucker; Rochelle N Naylor; Graeme I Bell; Louis H Philipson
Journal:  Trends Endocrinol Metab       Date:  2010-04-29       Impact factor: 12.015

Review 5.  Review. SUR1: a unique ATP-binding cassette protein that functions as an ion channel regulator.

Authors:  Jussi Aittoniemi; Constantina Fotinou; Tim J Craig; Heidi de Wet; Peter Proks; Frances M Ashcroft
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2009-01-27       Impact factor: 6.237

Review 6.  Insights into pancreatic islet cell dysfunction from type 2 diabetes mellitus genetics.

Authors:  Nicole A J Krentz; Anna L Gloyn
Journal:  Nat Rev Endocrinol       Date:  2020-02-25       Impact factor: 43.330

Review 7.  KATP channels and cardiovascular disease: suddenly a syndrome.

Authors:  Colin G Nichols; Gautam K Singh; Dorothy K Grange
Journal:  Circ Res       Date:  2013-03-29       Impact factor: 17.367

8.  Wolcott-Rallison syndrome is the most common genetic cause of permanent neonatal diabetes in consanguineous families.

Authors:  Oscar Rubio-Cabezas; Ann-Marie Patch; Jayne A L Minton; Sarah E Flanagan; Emma L Edghill; Khalid Hussain; Amina Balafrej; Asma Deeb; Charles R Buchanan; Ian G Jefferson; Angham Mutair; Andrew T Hattersley; Sian Ellard
Journal:  J Clin Endocrinol Metab       Date:  2009-10-16       Impact factor: 5.958

9.  Clinical heterogeneity in patients with FOXP3 mutations presenting with permanent neonatal diabetes.

Authors:  Oscar Rubio-Cabezas; Jayne A L Minton; Richard Caswell; Julian P Shield; Dorothee Deiss; Zdenek Sumnik; Amely Cayssials; Mathias Herr; Anja Loew; Vaughan Lewis; Sian Ellard; Andrew T Hattersley
Journal:  Diabetes Care       Date:  2008-10-17       Impact factor: 17.152

10.  RNA processing and mRNA surveillance in monogenic diabetes.

Authors:  Jonathan M Locke; Lorna W Harries
Journal:  Gene Regul Syst Bio       Date:  2008-05-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.